News | October 07, 2023
Emmes acquires VaxTRIALS
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
New Board of Directors and management team at Suven Pharma also appointed
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Minister was briefed on the nationwide dengue situation
Subscribe To Our Newsletter & Stay Updated
